Literature DB >> 24613735

Posterior reversible encephalopathy syndrome: the endothelial hypotheses.

A Marra1, M Vargas2, P Striano3, L Del Guercio4, P Buonanno2, G Servillo2.   

Abstract

Posterior reversible encephalopathy syndrome (PRES) is characterised by headache, visual disorders, seizures, altered mentation, consciousness disturbances and focal neurological signs. Initially described in patients with pre and eclampsia, severe hypertension, posterior reversible encephalopathy syndrome can occur in other clinical conditions such as infection, sepsis, shock, cancer chemotherapy, autoimmune diseases and hypercalcemia. Pathogenesis of brain lesions in PRES is not full understood and two opposite theories have been proposed. Both models are based on the central role of hypertension. According to the first theory, hypertension could cause a breakdown of the autoregulatory system in cerebral circulation, leading to brain edema. The second theory suggests that hypertension causes activation of autoregulatory system, which finally results in a vasoconstriction of brain vessels with hypoperfusion, ischemia and subsequent fluid leakage. However a large number of patients, with PRES, doesn't show hypertension. We here describe the hypothesis of the crucial role of endothelial dysfunction and activation in PRES pathogenesis. Our hypothesis offers a common pathogenetic mechanism in which every PRES-related condition can be set. In our model, the activation of immune system and the consequent endothelial activation start a molecular cascade which finally causes the production of molecules which alter the normal homeostasis of blood-brain barrier. This alteration consists in a weakening of brain vessel tight junctions, which allows fluid leakage and edema. In this scenario, hypertension would be an epiphenomenon of the underlying mechanism and not the cause and, for this reason, it can be present or not in PRES.
Copyright © 2014. Published by Elsevier Ltd.

Entities:  

Mesh:

Year:  2014        PMID: 24613735     DOI: 10.1016/j.mehy.2014.02.022

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  49 in total

1.  Re: Guillain Barré syndrome-related posterior reversible encephalopathy syndrome.

Authors:  Fuldem Yildirim Donmez
Journal:  Neuroradiology       Date:  2015-04-16       Impact factor: 2.804

2.  The link between arterial blood pressure and vasogenic edema in pediatric PRES.

Authors:  Giulio Zuccoli; Ryan T Fitzgerald; Raffaele Nardone; Andre D Furtado; Hoda Abdel-Hamid
Journal:  Neuroradiology       Date:  2015-04-24       Impact factor: 2.804

3.  Posterior reversible encephalopathy syndrome with colitis in a patient treated with panitumumab.

Authors:  Céline Blaye; Xavier Buy; Marine Gross-Goupil; Didier Vincent; Claire Jamet; Paul Sargos; Stéphane Culine; Guilhem Roubaud
Journal:  Ther Adv Drug Saf       Date:  2017-01-16

4.  Pulsatility and high shear stress deteriorate barrier phenotype in brain microvascular endothelium.

Authors:  Fernando Garcia-Polite; Jordi Martorell; Paula Del Rey-Puech; Pedro Melgar-Lesmes; Caroline C O'Brien; Jaume Roquer; Angel Ois; Alessandro Principe; Elazer R Edelman; Mercedes Balcells
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

Review 5.  Anti-Angiogenic Tyrosine Kinase Inhibitors and Reversible Posterior Leukoencephalopathy Syndrome: Could Hypomagnesaemia Be the Trigger?

Authors:  Rashmi R Shah
Journal:  Drug Saf       Date:  2017-05       Impact factor: 5.606

6.  Spectrum of cerebral spinal fluid findings in patients with posterior reversible encephalopathy syndrome.

Authors:  Lars Neeb; Jenneke Hoekstra; Matthias Endres; Bob Siegerink; Eberhard Siebert; Thomas G Liman
Journal:  J Neurol       Date:  2016-01       Impact factor: 4.849

7.  Differential serum cytokine profile in patients with systemic lupus erythematosus and posterior reversible encephalopathy syndrome.

Authors:  J Merayo-Chalico; A Barrera-Vargas; G Juárez-Vega; J Alcocer-Varela; A Arauz; D Gómez-Martín
Journal:  Clin Exp Immunol       Date:  2018-01-16       Impact factor: 4.330

Review 8.  [Posterior reversible encephalopathy syndrome].

Authors:  M Fischer; E Schmutzhard
Journal:  Med Klin Intensivmed Notfmed       Date:  2016-06-06       Impact factor: 0.840

9.  Effect of blood pressure on reversible posterior leukoencephalopathy syndrome in pre-eclampsia or eclampsia.

Authors:  Fang Xiaobo; Liang Yanling; Chen Dunjin; He Fang; Chen Jia; Zhong Yuhua; Zhang Weixi
Journal:  Hypertens Res       Date:  2017-11-02       Impact factor: 3.872

Review 10.  Headache and acute stroke.

Authors:  Dara G Jamieson; Natalie T Cheng; Maryna Skliut
Journal:  Curr Pain Headache Rep       Date:  2014-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.